MYOG Antibody - #DF8273

>>买2送1 进行中>>
>>赠JD卡 进行中>>
(5)   (4)  
产品: MYOG 抗体
货号: DF8273
描述: Rabbit polyclonal antibody to MYOG
应用: WB
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog
蛋白号: P15173
RRID: AB_2841562

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1500 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售
相关下载
MS Report
HPLC Report
MSDS
说明书
COA
实验方案
WB Handbook
IHC Protocol
IF/ICC Protocol

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
MYOG Antibody detects endogenous levels of total MYOG.
RRID:
AB_2841562
引用格式: Affinity Biosciences Cat# DF8273, RRID:AB_2841562.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

bHLHc3; cb553; Class C basic helix-loop-helix protein 3; MYF 4; Myf-4; MYF4; MYOG; MYOG_HUMAN; Myogenic factor 4; Myogenic factor 4 myogenin; Myogenin; Myogenin myogenin factor 4; OTTHUMP00000039094;

抗原和靶标

免疫原:

A synthesized peptide derived from human MYOG, corresponding to a region within C-terminal amino acids.

基因/基因ID:
MYOG(4656)

文献引用

1). Effect of traction therapy on muscle satellite cell proliferation and differentiation in a rat model of knee stiffness. Stem cell research & therapy, 2024 (PubMed: 39707518) [IF=7.5]

Application: WB    Species: Rat    Sample:

Fig. 3 Results of protein expression levels of MyoD1, Pax7, Myf5 and MyoG. (A) Western blot of MyoG, Myf5, Pax7, MyoD1, and GAPDH. (B, C) Quantitative results of protein expression in rectus femoris muscle of each group on 10 and 20 days of traction treatment, respectively (n = 8). *P 
2). Paeoniflorin Ameliorates Skeletal Muscle Atrophy in Chronic Kidney Disease via AMPK/SIRT1/PGC-1α-Mediated Oxidative Stress and Mitochondrial Dysfunction. Frontiers in Pharmacology, 2022 (PubMed: 35370668) [IF=5.6]

Application: IF/ICC    Species: rat    Sample: GA muscle

FIGURE 2 | PF inhibited skeletal muscle atrophy in CKD model rats.(J) Sections of GA muscle from different groups were examined with immunofluorescence staining (200×) using anti MyoD (red), anti MyoG (red) and DAPI (blue).

Application: WB    Species: rat    Sample: GA muscle

FIGURE 2 | PF inhibited skeletal muscle atrophy in CKD model rats.(L) Representative immunoblotting of MAFbx, MuRF-1, MyoD, MyoG and GAPDH.
3). oar-miR-411a-5p Promotes Proliferation and Differentiation in Hu Sheep Myoblasts Under Heat Stress by Targeting SMAD2. Journal of cellular physiology, 2025 (PubMed: 39718049) [IF=4.5]
4). Kcnma1 is involved in mitochondrial homeostasis in diabetes-related skeletal muscle atrophy. The FASEB Journal, 2023 (PubMed: 36929614) [IF=4.4]
5). Overexpression of Dnmt3a ameliorates diabetic muscle atrophy by modulating Pten/Akt pathway. EXPERIMENTAL PHYSIOLOGY, 2020 (PubMed: 32964508) [IF=2.6]

Application: WB    Species: mouse    Sample: tibialis anterior muscles

FIGURE 3 |Overexpression of Dnmt3a restores the expression of myogenic regulatory factors in diabetic mice. (a) Real-time PCR analysis of relative mRNA levels of atrogin-1, MuRF1, Pax7, Myod1 and Myog in tibialis anterior muscles from the Control group, STZ group, STZ+Vector group and STZ+Dnmt3a group. (b) Western blot analysis of relative protein levels of atrogin-1, MuRF1, Pax7, Myod1 and Myog in tibialis anterior muscles from each group. n = 6 mice per group; **P < 0.01, ***P < 0.001

限制条款

产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）

产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.